Announcing the One Nucleus 2026 Awards Shortlist

One Nucleus is pleased to announce the shortlist for the One Nucleus Awards 2026.

The One Nucleus Award categories are structured to reflect that breadth of R&D, investment, service provision, and enabling support across the stakeholders.

Best Preclinical Stage R&D of the Year:
⭐ Axiom Therapeutics
⭐ LinkGevity
⭐ Immutrin
⭐C-Further
⭐Asgard Therapeutics

Best Clinical Stage R&D of the Year:
⭐ CellCentric
⭐ Alchemab Therapeutics Ltd
⭐ Hemab Therapeutics
⭐ Muna Therapeutics
⭐ Resolution Therapeutics

Best Use of Emerging Technology of the Year:
⭐ deepmirror
⭐ Luvida
⭐ ExpressionEdits
⭐ Unravel Health
⭐ Orbis Medicines

Best Non-Therapeutic R&D Company of the Year:
⭐ Profionics
⭐ Cizzle Bio, Inc.
⭐ VUGENE
⭐ MatriQx
⭐ Sano Genetics

Best Industry-Academia Deal of the Year:
⭐ GSK
⭐ Myricx Bio & Novartis
⭐ eXmoor Pharma & UCL
⭐ Lonza & UCL
⭐ Houdini Bio

Thank you to everyone who entered and congratulations to all the finalists. We wish you all good luck and look forward to celebrating with you at Genesis on 10 December.

A special thank you to all the judges for your support.